Fund
Intermountain Ventures
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 1
- Lead
- 0
- New entries
- 0
- Follow ons
- 1
- Latest operation
- 24 September 2026
- Sectors
- Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 24 Sept | United States, Biotech | Series C | 75 M$ | Existing investor |
Co investors 15 funds crossed
- 8VC 1 operation
- Alexandria Venture Investments 1 operation
- Amgen Ventures 1 operation
- Andreessen Horowitz 1 operation
- Catalio Capital Management 1 operation
- DFJ Growth 1 operation
- Discovery Ventures 1 operation
- Eli Lilly and Company 1 operation
- GRIDS Capital 1 operation
- LG Technology Ventures 1 operation
- Merck Global Health Innovation Fund 1 operation
- Premji Invest 1 operation
- Quadrille Capital 1 operation
- S32 1 operation
- Sigmas Group 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: United States.